The TERTp mutation demonstrated strong prognostic value in IDH‐mt adult‐type gliomas, all Grade 4 gliomas and IDH‐wt histology 3–3 gliomas, with the latter two cohorts encompassing not only adult‐type cases. This evidence concerns the gene IDH2 and central nervous system cancer.